Search Results

Baxter Announces U.S. FDA Clearance of Altapore Shape Bioactive Bone Graft for Use in Surgery

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced U.S. Food and Drug Administration (FDA) clearance of Altapore Shape Bioactive Bone Graft, the latest addition to the company’s next-generation bone graft substitute product line. Altapore Shape is designed to enhance bone growth and help achieve fusion, which can lead to reduced pain and other improved clinical outcomes for patients.

Baxter to Host Second-Quarter 2020 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its second-quarter 2020 financial results on Thursday, July 30, 2020, at 7:30 a.m. Central Time. To access the call, dial (844) 471-1702 (domestic) or (574) 990-3603 (international). Please dial into the call at least ten minutes prior to the start for the operator to connect you. The Conference ID is 2386827.

Baxter Publishes 2019 Corporate Responsibility Report, Highlighting Efforts to Make a Meaningful Difference as a Leading Global Corporate Citizen

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today released its 2019 Corporate Responsibility Report.

Celebrating an Influential Woman in Manufacturing

Confidence is key in a successful career

Creating a Digital Imprint Around the World

R&D director shares his passion for digital healthcare and diversity

Baxter Highlights New Data on the Role Technologies Play in Improving Care for Dialysis Patients During the 57th ERA-EDTA Virtual Congress

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced new data showing use of Baxter’s Sharesource remote patient management (telehealth) platform for automated peritoneal dialysis (APD) therapy performed in Colombia was associated with a 56% reduction in technique failure.

Baxter Senior Leadership Team Commitment to Addressing Racial Injustice

Our focus on Inclusion & Diversity (I&D) at Baxter has never been more compelling or urgent. Racism has been a longstanding and disturbing societal issue, and recent displays of racial injustice toward the Black community have rocked U.S. society to its core – with the impact resonating far beyond. The events are all the worse for playing out against a pandemic that’s compounding health and economic disparities globally.

Baxter to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast on Tuesday, June 9, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 9:40 a.m. Eastern Time.  The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through June 9, 2021.

Man on a Mission

Army veteran feels at home working at Baxter

Engineer Embraces New Challenges

"Take every opportunity you are given"